Research Facility

Tucson, Arizona 85719

1 studies enrolling now · 6 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Hypoactive Sexual Desire Disorder, Osteoarthritis, Ulcerative Colitis

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase — Stopped early
• Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase — Completed
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women — Completed